Zeronda Tyler 4

What Happened Zeronda Tyler, Chief Financial Officer of VYNE Therapeutics (VYNE), had 22,516 shares withheld by the company to satisfy tax withholding related to the vesting of restricted stock units (RSUs). The withholding was recorded at $0.90 per share for a total value reported as $20,210. This is a tax-withholding disposition (transaction code F), not a market sale or cash purchase.

Key Details

• Transaction date: 2026-07-23; Filing date (Form 4): 2026-07-24 (timely).
• Transaction type/code: Tax withholding in connection with RSU vesting (F).
• Shares withheld/disposed: 22,516 at $0.90 per share; total reported value $20,210.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Shares were withheld by the issuer to satisfy tax withholding requirements for vesting of restricted stock units (F1).
• Filing timeliness: Report appears to be filed promptly (next business day).

Context Tax-withholding dispositions are a routine administrative step when RSUs vest; the company retains (withholds) a portion of the vested shares to cover payroll/tax obligations. This type of transaction generally does not signal an executive decision to sell shares on the open market and should be viewed as neutral from a trading-sentiment perspective.